推薦產品
化驗
99% (TLC)
形狀
powder
包裝
package of 1 × 1 mg (870308P-1MG)
package of 1 × 5 mg (870308P-5MG)
製造商/商標名
Avanti Research™ - A Croda Brand
運輸包裝
dry ice
儲存溫度
−20°C
SMILES 字串
[O-]P(OC([2H])([2H])C([2H])([2H])[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])(OC([2H])([2H])[C@]([2H])(O)C([2H])([2H])OC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C
一般說明
16:0 Lyso PC-d49 (1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (d49) is a deuterated derivative of 16:0 Lyso PC. Lyso PC is obtained from the hydrolysis of phosphatidylcholine (PC) by phospholipase A.[1]
包裝
5 mL Amber Glass Screw Cap Vial (870308P-1MG)
5 mL Amber Glass Screw Cap Vial (870308P-5MG)
5 mL Amber Glass Screw Cap Vial (870308P-5MG)
法律資訊
Avanti Research is a trademark of Avanti Polar Lipids, LLC
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine (lysoPC) in ovarian cancer patients
Okita M, et al.
International Journal of Cancer. Journal International Du Cancer, 71(1), 31-34 (1997)
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務